Carnegie Lake Advisors LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 3.7% during the fourth quarter, HoldingsChannel reports. The fund owned 3,236 shares of the company’s stock after selling 125 shares during the quarter. Carnegie Lake Advisors LLC’s holdings in GE HealthCare Technologies were worth $253,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies during the third quarter worth about $31,000. Finally, Continuum Advisory LLC lifted its stake in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $87.50 on Tuesday. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.55. The company has a market cap of $39.98 billion, a PE ratio of 24.04, a P/E/G ratio of 2.93 and a beta of 1.15. The stock has a 50-day moving average of $83.43 and a 200-day moving average of $85.34. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.
GE HealthCare Technologies Increases Dividend
Analyst Ratings Changes
A number of analysts have weighed in on GEHC shares. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $96.00.
Read Our Latest Analysis on GEHC
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
- Five stocks we like better than GE HealthCare Technologies
- How to Invest in Small Cap Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Short Nasdaq: An Easy-to-Follow Guide
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is Forex and How Does it Work?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.